John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Future of AI science? "Weโ€™re seeing agents actually trying to reproduce each otherโ€™s work, to check whether they want to build on that work.โ€โ€”@SRSchmidgall A landmark study on agentic driven science science.org/content/article/โ€ฆ @ScienceMagazine by @T_E_Howarth alphaxiv.org/abs/2611.societโ€ฆ @askalphaxiv
10
24
58
8,043
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Iโ€™m a cardiologist who started practicing in the years right before the ACA passed. At the time, I assumed the health policy professionals knew what they were doing and would design a system that improved things for patients and physicians. I was wrong. Watching the revisionism from the health policy class about what actually happened after passage has been something to behold. Anyone who still claims the Affordable Care Act lowered the federal deficit or made health care more affordable cannot be taken seriously on this topic. They may believe it in good faith, but a credential plus that belief does not entitle them to more say on future health policy than a random person on the street. The strongest positive claim one can make is narrow: a small group of previously uninsurable patients (roughly 3% of the population) gained access to insurance. Policymakers took a real problem affecting a small minority and used it to fundamentally redesign the entire health care system. The result made things worse for the other 97%. That is not a hypothetical. In practice, the law created a mechanism to funnel large sums of taxpayer money to insurance companies and Medicaid managed-care middlemenโ€”on the order of $800 billion in subsidies for ACA plans and another $800 billion in federal dollars to states for Medicaid expansion. The CBO scored this as paid for primarily through higher taxes and reduced Medicare payments to hospitals. Because the ACA mandated essential health benefits and community rating, and because insurers knew government subsidies would kick in, premiums rose sharply even as deductibles on these plans reached thousands of dollars. Individuals were then required to buy one of these products or pay a penalty. For physicians, the law built the first major penalty-based quality-reporting apparatus. This added overhead and cost for a set of largely clinically meaningless metrics, which contributed to many doctors retiring early or selling their practices to hospitals. On the fiscal side, the tax increases and Medicare payment cuts covered a portion of the new spending on paper. What the CBO did not adequately account for was the fraud and waste incentives created by a 90/10 federal match on expansion populations. When the state and managed-care organizations receive 90 cents on the dollar for every enrollee, the incentive to rigorously verify eligibility is weak. When federal dollars are flowing into home care, learning centers, and similar services that boost the local economy, states have little reason to aggressively pursue fictional or inflated claims. Medicaid spending is now roughly 20% higher than earlier projections. Any serious attempt to slow that growth is met with academic preprints and media coverage warning that large numbers of people will die. Helping a small number of previously uninsurable patients did not require redesigning the entire health care system around subsidies, mandates, community rating, and penalty-based reporting. That redesign raised costs, accelerated consolidation, and created spending dynamics that are now treated as untouchable. The results are visible. The revisionism is not.
An extremely narrow field of view from Fiedler on Obamacare : 1. Actual Medicaid spending has far outstripped early projections. CMS reports tens of billions in improper payments annually. Independent analyses put millions of expansion enrollees as likely ineligibleโ€”ghosts and fraud CBO never fully scored. 2. Medicare payment cuts didnโ€™t magically create free savings. Hospitals consistently report Medicare/Medicaid underpayments. The gap was just shifted onto commercial insurers and the uninsured. It isnโ€™t an accident that hospital Private rates run 200-250% of Medicare. Those โ€œsavingsโ€ Fiedler is pumped about just became higher premiums for everyone else. 3. Essential health benefits + community rating (and a healthy dose of consolidation driven by the ACA) produced major premium increases for people buying coverage on their own. Benchmark premiums rose ~75% from 2014โ€“2024 (and more for older enrollees)โ€”roughly double the growth in employer plans. Thatโ€™s a large, unaccounted-for tax on families Bottom line: If the goal was deficit reduction, raise taxes. Donโ€™t pair the tax increases with a massive new spending entitlement and a regulated individual market that has driven large premium inflation.
195
1,036
137
3,287
126,907
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
All webinars from Issue 3 of the ESC Bench to Bedside series, focusing on amyloidosis, are now available on demand. ow.ly/xp7i5107C6h Explore emerging therapies, clinical trial evidence and practical insights into treatment sequencing and patient selection. Register today for the upcoming Issue 4 webinars on hypertrophic cardiomyopathy. ow.ly/6A0c5107C6e #Cardiomyopathy #Amyloidosis #Cardiology
6
9
1,368
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Moore et al. support the potential of low-dose chest CT to do double duty: CAC classification remained highly reproducible despite a major reduction in radiation dose, offering another opportunity for cardiovascular risk assessment. doi.org/10.1016/j.jcct.2026.โ€ฆ
3
3
205
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
An analysis finds that many undesirable LLM behaviours dissipate after about 16 months go.nature.com/4zGDVuo
3
8
1
29
11,689
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
๐Ÿซ€ New #JACCINT: #TAVR vs #SAVR for isolated native #AR! ๐Ÿฅ TAVR offered shorter stays and similar 5-year survival, but more pacemakersโšกand repeat valve interventions ๐Ÿ”„. Important real-world comparative data! ๐Ÿ“Š bit.ly/4ztHRyv
22
73
6,633
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
How can we advance students from comprehension to prediction in physiology? Using the classic Wiggers diagram, this work demonstrates a logic-driven approach to connecting mechanistic events and supporting causal reasoning. E. P. Silldorff et al. ow.ly/NqYi51065bI
8
1
17
1,081
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Original Article: Prasugrel versus Ticagrelor in Acute Coronary Syndromes (SWITCH-SWEDEHEART trial) nej.md/4wGVCZd Editorial: The Emerging Role of Treatment Policy Implementation Trials in Acute Coronary Syndrome nej.md/45FxURZ #ESCCongress #Cardiology
8
38
159
26,675
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Here is a trial that needs to be repeated and finished ASAP
AF pt unsuitable for OAC? ASAP-TOO RCT of LAAC vs SAPT/no antithrombotic was underpowered due to poor accrual. No significant diff in ischemic stroke/systemic embolism. #LAAC overall low risk for complications. NEW LAAC focus issue of #JACC: bit.ly/4iJ8Mjr @bbikdeli
5
10
86
15,752
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Is โ€œmoderate drinking is good for the heartโ€ still true? New review on alcohol and cardiovascular disease: inter-organ crosstalk, microvascular dysfunction and accelerated cardiovascular ageing. Time to rethink the glass. Read more in #EHJ. doi.org/10.1093/eurheartj/ehโ€ฆ #cardiotwitter @ESC_Journals @escardio
3
67
6
200
20,244
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Looking for a practical guide to bifurcation PCI? ๐Ÿ“– The SCAI PCI for Coronary Bifurcation Lesions ebook brings together leading experts to cover: โ€ข Provisional vs. two-stent strategies โ€ข IVUS and OCT optimization โ€ข Left main bifurcation PCI โ€ข DK Crush, Culotte, TAP, and more Plus procedural technique videos demonstrating key approaches. Download for free today โžก๏ธ scai.org/publications/ebooksโ€ฆ #InterventionalCardiology #CardioX #CardioEd #PCI @DrMauricioCohen @KateKearney4 @ArasiMaran
42
175
12,599
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
In a new #ScienceReview, researchers discuss the emerging effects obesity medications, such as GLP-1-based therapies, have on cognition and brain health. Learn more: scim.ag/4k1BH4z
9
34
1
114
22,794
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Chest pain in the Emergency Department: is it the aorta? New acute aortic syndrome rule-out criteria, developed and externally validated, to safely skip CT in low-risk patients. Fewer missed dissections, fewer unnecessary scans. Read more in #EHJ. doi.org/10.1093/eurheartj/ehโ€ฆ #aorta #emergency #cardiotwitter @ESC_Journals @escardio
3
32
121
11,249
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
๐Ÿซ€ Could arterial stiffness help predict outcomes after cardiac surgery? Beyond blood pressure, arterial stiffness may impair ventricularโ€“arterial coupling and is associated with postoperative kidney injury, myocardial ischemia, heart failure and stroke. This review explores assessment methods, prognostic implications and perioperative strategies. Read more: imrpress.com/journal/RCM/27/โ€ฆ ๐Ÿ‘ฅ Authors: Fabio Anastasio, Guido Pastorini @Egocardio , Alessandro Gonella, Mauro Feola. ๐Ÿฅ Affiliations: Hospital of Mondovรฌ, Azienda Sanitaria Locale CN1 (ASLCN1). #CardiacSurgery #ArterialStiffness #Cardiology
1
3
1
11
516
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Soon none will like to go into the cathlab without having a proper Cardiac CT to fine the planning of coronary procedures. This is what happened already for Thoracic and Abdominal surgery, for Vascular Surgery/Intervention, and so forth. 3-4 decades ago CT was considered agonizing because MR was going to take over and look where we are now. โค๏ธ๐Ÿ˜„
1
1
1
17
5,309
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
How multimodal AI, combined with blood test omics via "liquid biopsies," will transform cancer monitoring and enable earliest detection. open-access @CellCellPress cell.com/cell/fulltext/S0092โ€ฆ
12
62
2
233
25,356
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
The expansion of kinase drug discovery: new targets, platforms and indications nature.com/articles/s41573-0โ€ฆ rdcu.be/58kHQSQ3Xcna This new Review analyses the kinase therapeutic landscape, covering more than 2,100 kinase-targeting agents that have entered clinical development
88
4
362
16,267
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
โœ… 4 drug classes cut HFrEF deaths: ARNI, BB, MRA, SGLT2i โ€จโŒ 30 others with great rationale failed in Phase 3 RCTs โ€จ๐Ÿ‡บ๐Ÿ‡ธ Only 18% get all 4 โ†’ ~114K US deaths preventable/yr โ€จ๐ŸŽฏ Implement GDMT with the same intensity we test new drugs โ€จ#HFrEF #CardioTwitter @HFSA @ACCinTouch
3
10
20
1,391
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Google published a paper that might end the PhD. Itโ€™s called โ€œScientistTwoโ€ For centuries, the bottleneck to human knowledge has been the human brain. It takes five years of grueling labor to read the literature, find a gap, formulate a hypothesis, run the experiments, and write the paper. But, Google automated the entire pipeline. They built an AI that reads a problem, forms hypotheses, runs experiments, writes the paper, AND simulates its own peer review. no human touches it. It reads millions of papers to find blind spots in the current science. It generates novel hypotheses. It designs the experiments. It writes the code to test them. When the code fails, it debugs itself. When the results come in, it analyzes the data, generates the charts, and writes the final academic paper. It even simulates a brutal peer-review process to critique and improve its own work before it considers the project finished. This isn't an LLM summarizing a PDF. This is a fully autonomous digital scientist. What takes a human candidate half a decade of massive intellectual effort... the AI accomplishes in a fraction of the time, at a fraction of the cost. The implications are staggering. If you can spin up 10,000 autonomous researchers overnight, the rate of scientific discovery is about to go vertical. We are moving from artisanal, human-speed research to industrialized knowledge creation. But it raises an uncomfortable reality for academia. When an AI can read the literature, design the experiment, execute the code, and write the paper... What exactly is the human supposed to do?
91
318
72
1,417
147,934